The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAquila Euro. Regulatory News (AERI)

Share Price Information for Aquila Euro. (AERI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.724
Bid: 0.71
Ask: 0.738
Change: 0.00 (0.00%)
Spread: 0.028 (3.944%)
Open: 0.724
High: 0.00
Low: 0.00
Prev. Close: 0.724
AERI Live PriceLast checked at -
Aquila European Renewables Income is an Investment Trust

To generate stable returns, principally in the form of income distributions, by investing in a diversified portfolio of Renewable Energy Infrastructure Investments.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Publication of Suppl.Prospcts

27 Aug 2021 16:45

RNS Number : 0754K
Aquila European Renewables Income
27 August 2021
 

 Aquila European Renewables Income Fund PLC

Publication of Supplementary Prospectus

27 August 2021

 

Aquila European Renewables Income Fund PLC (the "Company"), announces that it has today published a supplementary prospectus approved by the FCA (the "Supplementary Prospectus"). The Supplementary Prospectus is supplemental to, and should be read in conjunction with, the prospectus published by the Company on 17 September 2020 (the "Prospectus").

The Supplementary Prospectus will be submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism and on the Company's website at www.aquila-european-renewables-income-fund.com.

Sponsor, Broker and Joint Bookrunner in the UKNumis Securities (UK Investors) | +44 (02)0 7260 1000Tod DavisDavid BendaVicki Paine

Joint BookrunnerKempen & Co (EU Investors in the Target Jurisdictions) | +31 (0) 20 348 8000

Thomas ten Hoedt

Maarten de Zeeuw

 

 

Administrator and Company Secretary

PraxisIFM Fund Services (UK) Limited | +44 (0) 20 7332 2986

Brian Smith

 

 

Important Information

 

The distribution of this Announcement and/or the issue of New Ordinary Shares ("New Shares") in certain jurisdictions under the Placing Programme may be restricted by law and/or regulation. No action has been taken by the Company, Numis Securities Limited ("Numis") or Van Lanschot Kempen N.V. ("Kempen & Co") or any of their respective affiliates that would permit an offer of New Shares or possession or distribution of this Announcement or any other publicity material relating to such shares in any jurisdiction where action for that purpose is required. Persons receiving this Announcement are required to inform themselves about and to observe any such restrictions.

 

Numis, which is authorised and regulated in the United Kingdom by the FCA, is acting exclusively for the Company and no-one else in connection with the Issue or the Placing Programme or in relation to the matters referred to in the Prospectus and will not regard any other person (whether or not a recipient of this document) as its client in relation to the Issue or the Placing Programme and will not be responsible to anyone other than the Company for providing the protections afforded to its clients or for providing advice in relation to the Issue or the Placing Programme, the contents of this document or any transaction or arrangement referred to in the Prospectus.

Kempen & Co, which is authorised and regulated in the Netherlands by the Dutch Authority for Financial Markets and the Dutch Central Bank, is acting exclusively for the Company and no-one else in connection with the Placing and the Placing Programme or in relation to the matters referred to in the Prospectus, will not regard any other person (whether or not a recipient of this document) as its client in relation to the Placing or the Placing Programme and will not be responsible to anyone other than the Company for providing the protections afforded to its clients or for providing advice in relation to the Placing or the Placing Programme, the contents of this document or any transaction or arrangement referred to in the Prospectus. Kempen & Co is not acting for or providing services to the Company or any other person in respect of the Offer for Subscription and will not be responsible to any person in respect of any claim or any other matter arising from the Offer for Subscription.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PSPPPUWCRUPGGAM
Date   Source Headline
1st Mar 20237:00 amRNSTotal Voting Rights
28th Feb 20235:27 pmRNSTransaction in Own Shares
27th Feb 20234:44 pmRNSTransaction in Own Shares
24th Feb 20232:25 pmRNSTransaction in Own Shares
22nd Feb 20235:49 pmRNSTransaction in Own Shares
22nd Feb 20237:00 amRNSExchange rate for 4th Interim Dividend
21st Feb 20235:29 pmRNSTransaction in Own Shares
20th Feb 20234:44 pmRNSTransaction in Own Shares
16th Feb 20235:24 pmRNSTransaction in Own Shares
15th Feb 20234:15 pmRNSTransaction in Own Shares
15th Feb 20231:31 pmRNSHolding(s) in Company
14th Feb 20235:54 pmRNSTransaction in Own Shares
10th Feb 20235:30 pmRNSTransaction in Own Shares
9th Feb 20236:00 pmRNSTransaction in Own Shares
3rd Feb 20236:07 pmRNSDirector/PDMR Shareholding
3rd Feb 20236:05 pmRNSDirector/PDMR Shareholding
3rd Feb 20234:37 pmRNSPurchase of Shares for the Manager
3rd Feb 20237:00 amRNSDividend Declaration
3rd Feb 20237:00 amRNSNet Asset Value and Factsheet
3rd Feb 20237:00 amRNSDividend Guidance and Buyback Programme
2nd Feb 20235:39 pmRNSNew Remuneration & Nomination Committee Chair
26th Jan 20235:39 pmRNSHolding(s) in Company
18th Jan 20232:24 pmRNSHolding(s) in Company
17th Jan 20237:00 amRNSName Change of Company Secretary & Administrator
22nd Dec 202210:04 amRNSProject Greco Update
1st Dec 202211:40 amRNSImprovement to GRESB Score
24th Nov 20224:00 pmRNSExchange rate for 3rd Interim Dividend
21st Nov 20222:57 pmRNSThe Rock Update
9th Nov 20222:20 pmRNSPurchase of Shares for the Investment Adviser
8th Nov 20228:05 amRNSChange of Name & Change of AIFM Name
4th Nov 20227:00 amRNSNet Asset Value and September Factsheet
4th Nov 20227:00 amRNSDividend Declaration
31st Oct 20227:00 amRNSChange of Name
3rd Oct 202210:41 amRNSPower Price Agreement Signed for Project Greco
27th Sep 20227:00 amRNSHalf-year Report
24th Aug 20221:39 pmRNSExchange rate for 2nd Interim Dividend
5th Aug 20225:30 pmRNSPurchase of Shares for the Manager
4th Aug 20227:00 amRNSNet Asset Value & Quarterly Factsheet
4th Aug 20227:00 amRNSDividend Declaration
1st Jul 20227:00 amRNSTotal Voting Rights
29th Jun 20223:29 pmRNSTiza acquisition
27th Jun 20227:00 amRNSUpdates on Albeniz and The Rock
22nd Jun 202212:21 pmRNSAGM Result - REPLACEMENT
9th Jun 20224:32 pmRNSResult of AGM
8th Jun 202210:31 amRNSRCF Increase to EUR 100 million
1st Jun 20227:00 amRNSIssue of Equity & Total Voting Rights
16th May 20227:00 amRNSTiza acquisition
10th May 20227:00 amRNSDividend Declaration
10th May 20227:00 amRNSNet Asset Value & Factsheet
10th May 20227:00 amRNSDesfina Refinancing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.